Updated:
LENSAR
LENSAR is based in Orlando; the profile covers headquarters, registration, AUM band and key contacts for private-markets fundraising.
Overview
Explore LENSAR's next-gen femtosecond laser technology that guides superior astigmatism management and optimized visual outcomes.
General information
Location
Region
North America
Country
United States
City
Orlando
Corporate office
2800 Discovery Drive, Orlando, FL 32826, United States
Additional offices
Irvine, CA, United States · Hong Kong
Principals
Kerry Solomon
Medical Advisory Board Member
Sector focus
Frequently asked questions
What does LENSAR do with its capital?
LENSAR operates as a medical device manufacturer, not an investment firm. It develops and sells robotic cataract laser systems. Its capital is deployed into R&D, manufacturing, and commercial operations.
Who are LENSAR's known competitors?
LENSAR competes with Johnson & Johnson (via its femtosecond laser platform) and Alcon (LenSx laser). The robotic cataract surgery market also includes Ziemer Ophthalmic Systems.
What clinical outcomes does LENSAR claim?
LENSAR cites data on file from 2024 and a study by Orr MG (2021) comparing astigmatism correction rates using its system versus intraoperative aberrometry.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: